OPTOMETRIC SEMINAR
Ocular Disease Unlocked: Clinical Decision-Making for Today’s Eye Care Provider
SEMINAR FEATURES
- Date
- Jul 29 - Aug 8, 2027
- Credits
- 12 CE
Course Fees
- Registration
- $895
- Opticians
- $595
- Staff
- $145
- GROUPS: Please call
*Discounted fee based upon purchase of vacation package. If purchased separately, please add $400 to the above fees.
ABOUT THE SEMINAR
This engaging, case-driven 12-hour CE program focuses on sharpening diagnostic accuracy and improving treatment decisions using practical, real-world strategies clinicians can immediately apply in practice. You will master the clinical decisions that separate routine care from exceptional patient outcomes and walk away with clear, actionable clinical algorithms
Course Content
- Step-by-step approach to diagnosing ocular disease
- Pharmacologic decision-making made simple
- Glaucoma management for real-world practice
- Ocular surface and inflammatory disease strategies
- Neuro-ophthalmic conditions you must recognize
- Subtle findings that signal serious disease
- Case-based clinical problem solving
Learning Objectives
- Diagnose ocular disease with greater confidence
- Select appropriate pharmacologic treatments quickly and effectively
- Improve clinical decision-making efficiency
- Build confidence managing challenging and complex cases
- Strengthen your approach to glaucoma and ocular disease management
- Recognize when referral or imaging is necessary
- Apply simplified clinical algorithms
- Enhance outcomes through case-based learning
ABOUT THE INSTRUCTOR
Dr. Ron Melton is an internationally recognized leader in ocular disease and medical optometry, known for delivering high-yield, clinically relevant education that directly impacts patient care. He has presented more than 1,000 continuing education lectures worldwide and is widely respected for his ability to translate complex topics into practical, real-world clinical decision-making. He has authored or co-authored over 100 publications and is best known as co-author of the Clinical Guide to Ophthalmic Drugs, a cornerstone resource in clinical optometry for over 25 years. He serves on the editorial advisory board for Review of Optometry.
Dr. Melton is a Diplomate of the American Board of Optometry and has participated in more than 60 clinical research trials. He is on the adjunct faculty at both the Indiana University School of Optometry and the Pennsylvania College of Optometry at Drexel University. His honors include the 2024 Golden ICARE Award, recognition among Newsweek’s America’s Best Optometrists (2021–2023), and the American Academy of Optometry’s Vincent Ellerbrock Clinician Educator Award.
He practices in Charlotte, North Carolina, and holds hospital privileges at Novant Health Presbyterian Medical Center.
